title: Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation.
abstract: In a 34-year-old patient toxoplasma retinitis/encephalitis developed 9 months after bone marrow transplantation. The BMT was complicated with a serious GVHD. Although she initially responded well to antibiotic therapy she died 2 years after BMT due to progressive infection.
authors.affiliation: Department of Internal Medicine, University Hospital, Nijmegen, The Netherlands.
authors.forename: K
authors.initials: K
authors.lastname: Brinkman
authors.forename: S
authors.initials: S
authors.lastname: Debast
authors.forename: R
authors.initials: R
authors.lastname: Sauerwein
authors.forename: F
authors.initials: F
authors.lastname: Ooyman
authors.forename: J
authors.initials: J
authors.lastname: Hiel
authors.forename: J
authors.initials: J
authors.lastname: Raemaekers
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002981:Clindamycin / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D016781:Toxoplasmosis, Cerebral / Q000188:drug therapy / Q000209:etiology*; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000890:Anti-Infective Agents; D007166:Immunosuppressive Agents; D013411:Sulfadiazine; D002981:Clindamycin; D011739:Pyrimethamine